Latest Breaking News On - Maat pharma - Page 9 : comparemela.com

MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising t

Article 223-16 of the General Regulations of the Financial Markets Authority (AMF - Autorité des Marchés Financiers)LYON, France (BUSINESS WIRE) $MAAT Regulatory News:MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem Therap.

Pauline richaudGuilhaume debroasRegulations of the financial markets authorityCorporate communicationsTrophic communicationsGeneral regulationsFinancial markets authorityDes marchRegulatory newsMicrobiome ecosystemFrench commercial codeFrench autoritMaat pharmaMicrobiome ecosystem therapiesEuronext parisInvestor relations

Alliance Promotion Microbiote To Welcome Ferring Pharmaceuticals, Pelican Health and Polepharma as New Members

Alliance Promotion Microbiote To Welcome Ferring Pharmaceuticals, Pelican Health and Polepharma as New Members
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Haute normandieSwitzerland generalPhilippe niezBiose industrieThomas soranzoEligo bioscienceAlliance promotion microbioteContact alliance promotionPelican healthFerring pharmaceuticalsLallemand health solutionsMedical directorAlliance promotion microbiote createdLuxia scientificMaat pharmaSeventure partners

MaaT Pharma Provides Third Quarter 2023 Business Update and Reports Financial Results

MaaT Pharma Provides Third Quarter 2023 Business Update and Reports Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesCity ofUnited kingdomSan franciscoLou gehrigEarly access program of maaSenior pr corporate communicationsCompany early access program of maaCellulaire congressTrophic communicationsEuropean medicines agencyMicrobiome therapeutics innovation groupSociety for immunotherapy of cancerAmerican society of hematologyIndependent data safety monitoring board

MaaT Pharma Provides Third Quarter 2023 Business Update and Reports Financial Results

MaaT Pharma Provides Third Quarter 2023 Business Update and Reports Financial Results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesUnited kingdomCity ofSan diegoLou gehrigMicrobiome therapeutics innovation groupEarly access program of maaAmerican society of hematologyCellulaire congress boothSenior pr corporate communicationsSociety for immunotherapy of cancerCompany early access program of maaTrophic communicationsEuropean medicines agencyIndependent data safety monitoring board

MaaT Pharma Provides Third Quarter 2023 Business Update and Reports Financial Results

Independent Data Safety Monitoring Board (DSMB) reviewing the Phase 3 ARES trial evaluating MaaT013 in aGvHD concluded on a positive benefit/risk ratio based on a good safety profile and positive preliminary efficacy results with an Overall Response Rate higher than pre-defined protocol assumptionsResults from the C.

United kingdomSan diegoUnited statesSan franciscoCity ofLou gehrigTrophic communicationsEuropean medicines agencySenior pr corporate communicationsMicrobiome therapeutics innovation groupAmerican society of hematologyEarly access program of maaCompany early access program of maaCellulaire congressSociety for immunotherapy of cancerIndependent data safety monitoring board